Consensus AbCellera Biologics Inc.

Equities

ABCL

CA00288U1066

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
3.76 ^USD	+3.58%		-2.84%	-34.15%

03-11	AbCellera, Biogen Collaborate to Discover Treatments for Neurological Diseases	MT
03-11	AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions	CI

Evolution of the average Target Price on AbCellera Biologics Inc.

Price target over the last 5 years

History of analyst recommendation changes

8c8d74f5e.SEtqhmNxsMCCuIu4E77mGQzbrhwI7RQSQHxiqxXORY8.D3w6zVUu0rj1wMbxUNCjLGXry3Jaq0x_DE8j5XeoNaIKcinAVzDC9srn3g~9845036073943feb8a15162dac2c8cbf

Analyst Recommendations on AbCellera Biologics Inc.

Benchmark Upgrades AbCellera Biologics to Buy From Hold, Price Target is $9	02-22	MT
Stifel Lowers Price Target on AbCellera Biologics to $17 From $21, Maintains Buy Rating	02-21	MT
KeyBanc Initiates AbCellera Biologics at Overweight With $6 Price Target, Cites 'Robust' Platform, 'Attractive' Valuation	12-05	MT
Piper Sandler Assumes AbCellera Biologics at Overweight With $20 Price Target	13/10/23	MT
Benchmark Adjusts AbCellera Biologics' Price Target to $12 From $20, Keeps Buy Rating	31/08/23	MT
Goldman Sachs Adjusts AbCellera Biologics' Price Target to $24 From $27, Keeps Buy Rating	04/08/23	MT
Berenberg Bank Adjusts AbCellera Biologics Price Target to $34 From $38, Maintains Buy Rating	04/08/23	MT
Credit Suisse Lowers AbCellera Biologics' Price Target to $28 From $34, Keeps Outperform Rating	05/05/23	MT
Cowen Starts AbCellera Biologics at Outperform	28/02/23	MT
BMO Capital Cuts Price Target on AbCellera Biologics to $32 From $40, Maintains Outperform Rating	22/02/23	MT
Berenberg Bank Adjusts AbCellera Biologics' Price Target to $38 From $43, Maintains Buy Rating	22/02/23	MT
Prospect of Further Federal Reserve Interest Rate Increases Pressuring Exchange-Traded Funds, Equity Futures	24/01/23	MT
Fed Rate Outlook, China Optimism Lift Exchange-Traded Funds, Equity Futures Pre-Bell	20/01/23	MT
SVB Securities Adjusts Price Target on AbCellera Biologics to $18 From $20, Maintains Outperform Rating	06/01/23	MT
Goldman Sachs Initiates AbCellera Biologics at Buy With $30 Price Target	15/12/22	MT
Truist Securities Starts AbCellera Biologics at Buy With $29 Price Target	16/11/22	MT
SVB Securities Raises Price Target on AbCellera Biologics to $20 From $13, Maintains Outperform Rating	09/11/22	MT
Piper Sandler Trims Price Target on AbCellera Biologics to $21 From $22, Maintains Overweight Rating	01/11/22	MT
Credit Suisse Lowers AbCellera Biologics' PT to $34 from $40, Updates Model with Q2 Actuals, Adjusts Near-Term Program Projections; Keeps Outperform Rating	10/08/22	MT
Piper Sandler Adjusts Price Target on AbCellera Biologics to $22 From $21, Reiterates Overweight Rating	26/07/22	MT
Piper Sandler Lowers AbCellera Biologics Price Target to $21 From $28, Overweight Rating Kept	11/05/22	MT
SVB Securities Adjusts AbCellera Biologics' Price Target to $14 from $20, Keeps Outperform Rating	11/05/22	MT
Berenberg Bank Raises Price Target on AbCellera Biologics to $43 From $42, Maintains Buy Rating	11/05/22	MT
Berenberg Discover AI Seminar	25/04/22	FA
Berenberg Bank Adjusts AbCellera Biologics' Price Target to $42 From $48, Maintains Buy Rating	01/03/22	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.76 USD

Average target price

14.75 USD

Spread / Average Target

+292.29%

High Price Target

28 USD

Spread / Highest target

+644.68%

Low Price Target

8 USD

Spread / Lowest Target

+112.77%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AbCellera Biologics Inc.

Benchmark Company
Stifel Nicolaus
KeyBanc Capital Markets
Piper Sandler
Goldman Sachs
Berenberg Bank
Credit Suisse
Cowen
BMO Capital
SVB Securities LLC
Truist Securities
SVB Leerink
Benchmark Capital

Ratings for AbCellera Biologics Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar